Medication-Assisted Treatment - Prescription Drug and Opioid Addiction
The purpose of this program is to expand access to medications for opioid use disorder, increasing availability of treatment and recovery for individuals with opioid use disorder, and to reduce illicit opioid use and prescription opioid misuse and overdose.
| Agency | Substance Abuse and Mental Health Services Adminis |
|---|---|
| Status | Forecasted |
| Opportunity number | TI-26-008 |
| Posted date | 03/20/2026 |
| Estimated total funding | 67,500,000 |
| Expected number of awards | 90 |
| Who can apply | Domestic public and private non-profit entities, including faith-based organizations. |
| Assistance Listing (CFDA) | 93.490 |
| Description | The purpose of this program is to expand access to medications for opioid use disorder, increasing availability of treatment and recovery for individuals with opioid use disorder, and to reduce illicit opioid use and prescription opioid misuse and overdose. |
| Agency contact | MAT-PDOA-C@samhsa.hhs.gov |
| Official listing | https://www.grants.gov/search-results-detail/361578 |